CVRx (CVRX) FCF Margin Growth (1y) (2021 - 2026)
CVRx (CVRX) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -473.00 |
| 10 | CVRx | 75.83 Mn | 11.25 Mn | 13.72 Mn | 225.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 225.00 |
| Mar 31, 2026 | 2,113.00 |
| Dec 31, 2025 | -878.00 |
| Sep 30, 2025 | 1,002.00 |
| Jun 30, 2025 | 2,710.00 |
| Mar 31, 2025 | 537.00 |
| Dec 31, 2024 | 1,830.00 |
| Sep 30, 2024 | -45.00 |
| Jun 30, 2024 | 5,006.00 |
| Mar 31, 2024 | 2,177.00 |
| Dec 31, 2023 | 8,134.00 |
| Sep 30, 2023 | 10,597.00 |
| Jun 30, 2023 | 6,532.00 |
| Mar 31, 2023 | 13,687.00 |
| Dec 31, 2022 | 5,431.00 |
| Sep 30, 2022 | 9,265.00 |
| Jun 30, 2022 | 1,747.00 |
| Mar 31, 2022 | -8,864.00 |
| Dec 31, 2021 | -605.00 |
| Sep 30, 2021 | 25,280.00 |